Cargando…

Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine

Detalles Bibliográficos
Autores principales:	Foung, Steven K. H., Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237980/ https://www.ncbi.nlm.nih.gov/pubmed/30473699 http://dx.doi.org/10.3389/fimmu.2018.02577

Ejemplares similares

Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine
por: Keck, Mei-Le, et al.
Publicado: (2018)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

Editorial: Immunology of HPV Infection and Vaccination: Progress and Challenges
por: Licciardi, Paul V., et al.
Publicado: (2021)

Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus
por: Fuerst, Thomas R., et al.
Publicado: (2018)

Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection
por: Hou, Wen, et al.
Publicado: (2021)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Neutralizing Antibody Response to Hepatitis C Virus
por: Wang, Yong, et al.
Publicado: (2011)

Editorial: Targeting the Immune System to Treat Hepatitis B Virus Infection
por: Meng, Zhongji, et al.
Publicado: (2022)

Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection
por: Ghasemi, Faezeh, et al.
Publicado: (2016)

Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies
por: Sandhu, Praneet, et al.
Publicado: (2017)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)

Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
por: Hou, Jue, et al.
Publicado: (2022)

CCHFV vaccine development, current challenges, limitations, and future directions
por: Ahata, Büşra, et al.
Publicado: (2023)

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
por: Bailey, Justin R., et al.
Publicado: (2019)

The Investigation of Hepatitis B Vaccine Immune Responses in Occult Hepatitis B Virus-Infected Patients
por: Peng, Jing, et al.
Publicado: (2022)

Immunotherapy for Glioblastoma: Current Progress and Challenges
por: Yu, Miranda W., et al.
Publicado: (2021)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
por: Sharma, Omna, et al.
Publicado: (2020)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
Publicado: (2021)

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections
por: Schrauf, Sabrina, et al.
Publicado: (2020)

Editorial: Irradiation technologies for vaccine development
por: Wijewardana, Viskam, et al.
Publicado: (2023)

Editorial: Why Vaccines to HIV, HCV, and Malaria Have So Far Failed—Challenges to Developing Vaccines Against Immunoregulating Pathogens
por: Li, Shuo, et al.
Publicado: (2015)

Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus
por: Mobini, Saeed, et al.
Publicado: (2020)

A Role for B Cells to Transmit Hepatitis C Virus Infection
por: Desombere, Isabelle, et al.
Publicado: (2021)

An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
por: Salas, Jordan H., et al.
Publicado: (2022)

Editorial: Pandemic influenza vaccine approaches: Current status and future directions
por: Schotsaert, Michael, et al.
Publicado: (2022)

Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information
por: Tagliabue, Aldo, et al.
Publicado: (2019)

Editorial: Understanding the Limitations of Current Influenza Vaccine Strategies and Future Development of More Efficacious Preventative and Therapeutic Interventions
por: Tripp, Ralph A., et al.
Publicado: (2019)

Interferon and Hepatitis B: Current and Future Perspectives
por: Ye, Jianyu, et al.
Publicado: (2021)

Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum
por: Ishfaq, Muhammad, et al.
Publicado: (2020)

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
por: Riet, Tobias, et al.
Publicado: (2022)

Hepatitis C Virus E2 Protein Ectodomain Is Essential for Assembly of Infectious Virions
por: Bianchi, Alessia, et al.
Publicado: (2011)

Hepatitis C Vaccines, Antibodies, and T Cells
por: Shoukry, Naglaa H.
Publicado: (2018)

Current Insights in the Development of Efficacious Vaccines Against RSV
por: Soto, Jorge A., et al.
Publicado: (2020)

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
por: Drummer, Heidi E.
Publicado: (2014)

Editorial: Challenges in Vaccinology
por: Lavelle, Ed C., et al.
Publicado: (2020)

Hepatitis C Virus Vaccine: Challenges and Prospects
por: Duncan, Joshua D., et al.
Publicado: (2020)

Hepatitis C virus: current concepts and future challenges
por: Klenerman, P., et al.
Publicado: (2012)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_as9mki9o82un96lsali4h1eigb